LHL Helse Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2005
NCT00249093
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Active Ingredients

Drugs in Other Trials (3)

ethanol (1 trial)

oxygen (3 trials)

zopiclone (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 3
  • # of Trial APIs: 3